AUSTRALIAN researchers have developed a world-first blood test which improves prediction of the risk of heart attack in those with severe coronary artery disease.
Published in PLOS One today, the Austin Health and University of Melbourne study found patients with coronary artery disease, who had a high level of the enzyme ACE2, were at higher risk of suffering a heart attack over the next 10 years.
Lead author Professor Louise Burrell says the study could change clinical practice for the leading cause of death in Australia.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Jun 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 18